Skip to content

Galera Therapeutics, Inc.

Delisted

CIK 1563577fmd_13RVDNEABJ92E8BGM8S4076KQYManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2018 to Mar 31, 2026, 33 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading